Policies and guidelines

Infection Prevention and Control Policy

This Policy Directive outlines practices required to minimise the risk of patients, visitors, volunteers and health workers acquiring a healthcare associated infection, multidrug-resistant organism colonisation or communicable disease.

The primary purpose of the NSW Health Infection Prevention and Control Policy is to provide leadership to NSW Health Organisations (including Affiliated Health Organisations) on how to effectively prevent, manage and control healthcare associated infections (HAIs), in order to minimise the adverse health impacts on patients treated within health care and reduce the burden of HAIs.

HAI Clinical Indicator Manual Version 3.3 - September 2021

This New South Wales (NSW) Healthcare Associated Infection (HAI) Clinical Indicator Manual outlines the minimum level of HAI surveillance that NSW public healthcare organisations (PHO) providing acute care services are to undertake. The Manual was developed in consultation with NSW local health districts (LHDs) and specialty health networks (SHNs) to provide healthcare facilities with a framework to conduct HAI surveillance activities in key areas of increased risk.

The goals of NSW HAI Surveillance are to:

  • Ensure appropriate clinical indicators are collected and reported in keeping with national and international recommendations
  • Ensure all NSW public healthcare organisations use standardised definitions and methodology
  • Ensure the data is valid and robust.

All facilities are expected to review their own data to identify issues and act on these in a timely manner.

The NSW HAI Clinical Indicator Manual contains the technical information to allow standardised definitions and methodology for surveillance personnel who are collecting and reporting data to the NSW Ministry of Health.

Practices recommended in this manual are based on the expectation that PHOs have at least basic infection prevention and control systems in place and adequate resources for surveillance, data collection, analysis and reporting.

To enable the CEC to better understand issues identified during the implementation of the Manual, this issues log has been developed for you to provide your feedback and suggestions on how the issue can be resolved. We welcome feedback on issues related to interpretation, collection, investigation, reporting and validation of the HAI Clinical Indicators. We will monitor the issues log regularly. Please click here.

Tools to support implementation

Surveillance and Response for Carbapenemase-Producing Enterobacterales (CPE) in NSW Health Facilities

This Guideline is designed to assist public health care facilities in NSW to:

  1. Identify suspected cases of Carbapenemase producing Enterobacterales (CPE)
  2. Implement control measures to prevent transmission of CPE
  3. Understand the local epidemiology of CPE.

While this Guideline has been written specifically for CPE, recommended measures may also be applicable to any species of multidrug-resistant Enterobacterales (MDR-E) and other carbapenemase producing organisms (CPO). The local decision whether to apply to other MDR-E and CPO is to be made in consultation with content experts. As evidence for recommendations continues to emerge, recommendations will be reviewed and revised when significant new findings are available.

Intravascular Access Devices (IVAD) - Infection Prevention & Control

The purpose of the NSW Health Intravascular Access Device (IVAD) Infection Prevention and Control Policy is to provide guidance to NSW Health Organisations (HO's) including Affiliated Health Organisations on the minimum standards for insertion, management and removal of IVADs, in order to minimise the adverse health impacts on patients and reduce burden of healthcare associated Infections (HAIs). This Policy is to be read in conjunction with NSW Health Infection Prevention and Control Policy.

Triggers for Escalation Following Detection of Infection Outbreaks or Clusters

This Guideline has been developed to support NSW public healthcare facilities with effective and timely escalation of information on outbreaks or clusters of healthcare associated infections, multidrug-resistant organisms (MROs) and/or non-MROs.